Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quercetin Nanoemulsion Ameliorates Neuronal Dysfunction in Experimental Alzheimer’s Disease Model
Nouf K. Alaqeel, Mona Hmoud AlSheikh, Mohammed Al-Hariri
Antioxidants (2022) Vol. 11, Iss. 10, pp. 1986-1986
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Recent Advances in Nanoformulations for Quercetin Delivery
Ekaterina‐Michaela Tomou, Paraskevi Papakyriakopoulou, Elmina-Marina Saitani, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1656-1656
Open Access | Times Cited: 53
The Role of Quercetin, a Flavonoid in the Management of Pathogenesis Through Regulation of Oxidative Stress, Inflammation, and Biological Activities
Hajed Obaid Alharbi, Mohammad Alshebremi, Ali Yousif Babiker, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 151-151
Open Access | Times Cited: 6
Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer’s disease
Hind Muteb Albadrani, Payal Chauhan, Sumel Ashique, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116376-116376
Open Access | Times Cited: 15
Polyherbal and Multimodal Treatments: Kaempferol- and Quercetin-Rich Herbs Alleviate Symptoms of Alzheimer’s Disease
Claire Alexander, Ali Parsaee, Maryam Vasefi
Biology (2023) Vol. 12, Iss. 11, pp. 1453-1453
Open Access | Times Cited: 19
A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory
Zhihan Chen, Xinrui Wang, Simin Du, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Anti-SARS-CoV-2, antioxidant and immunomodulatory potential of dietary flavonol quercetin: Focus on molecular targets and clinical efficacy
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 10, pp. 100125-100125
Open Access | Times Cited: 14
Neuroprotective Role of Phytoconstituents-based Nanoemulsion for the Treatment of Alzheimer’s Disease
Sukriti Vishwas, Bushra Bashir, Devendra Birla, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1683-1698
Closed Access | Times Cited: 5
The role of quercetin in NLRP3-associated inflammation
Jiaqi Wu, Tongtong Lv, Yü Liu, et al.
Inflammopharmacology (2024)
Closed Access | Times Cited: 5
Quercetin-loaded nanoemulsions prevent Scopolamine-induced neurotoxicity in male rats
Reza Babanzadeh, Seyed Yaser Vafaei, Davood Ahmadi Moghadam, et al.
Physiology & Behavior (2024) Vol. 277, pp. 114494-114494
Closed Access | Times Cited: 4
Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems
Komaldeep Kaur, Yogesh A. Kulkarni, Sarika Wairkar
Brain Research (2024) Vol. 1834, pp. 148905-148905
Closed Access | Times Cited: 4
Promising Natural Remedies for Alzheimer’s Disease Therapy
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 922-922
Open Access
Probiotic-fermented ginger-processed Gastrodia elata BI. Ameliorates AlCl3-induced cognitive dysfunction in an Alzheimer's disease rat model by regulating the gut microbiota and CREB/BDNF pathway
Junyuan Huang, Lanyu Lai, Yilin Su, et al.
Food Research International (2025) Vol. 207, pp. 116087-116087
Closed Access
Nano lipid-drug conjugates for the treatment of Alzheimer’s disease
Subhajit Mandal, Malay K. Das
Elsevier eBooks (2025), pp. 237-291
Closed Access
Emerging nano-derived therapy for the treatment of dementia: a comprehensive review
Shadaan Ahmad, Lubna Ahmad, Mohammad Adil, et al.
Drug Delivery and Translational Research (2025)
Closed Access
Development of nanomedicines for the treatment of Alzheimer’s disease: Raison d’être, strategies, challenges and regulatory aspects
Farhan Mazahir, Md Imtiyaz Alam, Awesh K. Yadav
Ageing Research Reviews (2024) Vol. 98, pp. 102318-102318
Closed Access | Times Cited: 3
Role of Flavonoids in Mitigating the Pathological Complexities and Treatment Hurdles in Alzheimer's Disease
Shivani Chib, Bhaskar Jyoti Dutta, Rishabh Chalotra, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 3
Naringenin ameliorates Cyclophosphamide-induced nephrotoxicity in experimental model
Nouf K. Alaqeel, Mohammed Al-Hariri
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 6, pp. 103674-103674
Open Access | Times Cited: 9
Recent advances in brain delivery of synthetic and natural nano therapeutics: Reviving hope for Alzheimer's disease patients
Doaa Sayed Nady, Udo Bakowsky, Sherif Ashraf Fahmy
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105047-105047
Open Access | Times Cited: 7
Nanoformulations targeting Alzheimer's disease
Devesh U. Kapoor, Deepak Sharma, Yashwant Pathak, et al.
Elsevier eBooks (2024), pp. 265-282
Closed Access | Times Cited: 2
Development, optimization, and evaluation of Empagliflozin nanoemulsion for the management of neuroinflammation associated Alzheimer's disease
Nabil A. Alhakamy, Essam Ali Aljehani, Ashraf B. Abdel‐Naim, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105425-105425
Closed Access | Times Cited: 2
The Neuroprotective and Therapeutic Effects of Medicinal Plants and Natural Products against Aluminium Chloride-Induced Alzheimer’s Disease: Recent Update
Ayodeji Oluwatobi Ojetunde
Biology Medicine & Natural Product Chemistry (2024) Vol. 13, Iss. 1, pp. 7-33
Open Access | Times Cited: 2
The assessment of pharmacokinetics and neuroprotective effect of berberine hydrochloride-embedded albumin nanoparticles via various administration routes: comparative in-vivo studies in rats
Hany G. Attia, Maha E. Elmataeeshy, Mohamed Aleraky, et al.
Journal of Microencapsulation (2024), pp. 1-25
Closed Access | Times Cited: 2
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2
Phytochemical Interactions with Calmodulin and Critical Calmodulin Binding Proteins Involved in Amyloidogenesis in Alzheimer’s Disease
Danton H. O’Day
Biomolecules (2023) Vol. 13, Iss. 4, pp. 678-678
Open Access | Times Cited: 4
Formulation and optimization of fisetin nanoemulsion for the treatment of Alzheimer’s disease in rats: Pharmacokinetic and Pharmacodynamic assessment
Sukriti Vishwas, Rajan Kumar, Ankit Awasthi, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106269-106269
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top